Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid Dosing in Refractory Status Epilepticus
NCT01586208Phase 3Completed
- Sponsor
- Bellvitge University Hospital
- Start
- Jan 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valproic acid in status epilepticus (SE), sponsored by Bellvitge University Hospital. Started Jan 2010; status: completed.
02
Drugs
valproic acid
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT01586208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01586208.